Amwill Healthcare Limited (BSE SME)
Feb 5, 2025 - Feb 7, 2025
| Price | ₹105 - ₹111 |
| Premium | ₹0 |
|---|---|
| Lot size | 1200 |
| Allotment | Feb 10, 2025 |
| Listing | Feb 12, 2025 |
| Category | Lot(s) | Qty | Amount | Reserved |
|---|---|---|---|---|
| Retail | 1 | 1200 | 133200 | 1711 |
| HNI | 2 | 2400 | 266400 | 1711 |
Last updated on 07-Feb-2025 19:01:02
| Category | Offered | Applied | Times |
|---|---|---|---|
| QIBs | 1026000 | 8001600 | 7.8 |
| HNIs | 2053200 | 11892000 | 5.79 |
| Retail | 2053200 | 9789600 | 4.77 |
| Total | 5132400 | 29683200 | 5.78 |
| Total Applications: 12932 | |||
| QIB Interest Cost Per Share (7 Days) | |||||
|---|---|---|---|---|---|
| @7% ₹1.2 | @8% ₹1.3 | @9% ₹1.5 | @10% ₹1.7 | @11% ₹1.8 | @12% ₹2 |
| HNI Interest Cost Per Share (7 Days) | |||||
|---|---|---|---|---|---|
| @7% ₹0.9 | @8% ₹1 | @9% ₹1.1 | @10% ₹1.2 | @11% ₹1.4 | @12% ₹1.5 |
IPO Reservation
| Investor Category | Shares Offered | No. of Shares |
|---|---|---|
| Retail | 38.00% | 2053200 |
| NII (HNI) | 38.00% | 2053200 |
| QIB | 19.00% | 1026000 |
| Market Maker | 5.00% | 271200 |
| Total | 100.00% | 5403600 |
Amwill Healthcare IPO Details
| Issue Size | 54,03,600 shares (aggregating up to ₹59.98 Cr) |
| Fresh Issue | 44,03,600 shares (aggregating up to ₹ 48.88 Cr) |
| Offer for Sale | 10,00,000 shares of ₹10 (aggregating up to ₹11.10 Cr) |
| Issue Type | Book Built Issue IPO |
| Listing At | BSE SME |
| Share Holding Pre Issue | 1,56,00,000 shares |
| Share Holding Post Issue | 2,00,03,600 shares |
| Market Maker Portion | 2,71,200 shares |
| Market Maker | Globalworth Securities |
Key Performance Indicator
| KPI | Sep-24 | Mar-24 | Mar-23 |
|---|---|---|---|
| ROE | 27.52% | 73.06% | 67.67% |
| ROCE | 36.16% | 94.16% | 83.32% |
| RONW | 27.52% | 73.06% | 67.67% |
| EPS (basic) | 4.18 | 8.04 | 2.00 |
| P/E Pre IPO | 13.81 | ||
| P/E post IPO | 17.04 |
Company Financials In Crores
| Period Ended | Sep-24 | Mar-24 | Mar-23 | Mar-22 |
|---|---|---|---|---|
| Assets | 29 | 19 | 12 | 7 |
| Revenue | 23 | 44 | 30 | 28 |
| Profit After Tax | 7 | 13 | 3 | 3 |
| Net Worth | 24 | 17 | 5 | 1 |
| Reserves and Surplus | 8 | 17 | 5 | 1 |
About Company
Amwill Health Care Limited, incorporated in August 2017, is a derma-cosmetic development firm that collaborates with contract manufacturers, distributors, and third-party product development agencies to enhance its manufacturing, packaging, and distribution capabilities. The company's product portfolio is divided into generic dermatological solutions and targeted formulations for specific dermatological conditions, including acne, fungal infections, anti-aging, histaminic reactions, periorbital hyperpigmentation, scabies, perspiration, trichology, and vitiligo. Amwill Health Care currently markets its products in Karnataka, Andhra Pradesh, and Telangana, focusing on strengthening its presence before expanding into new regions. The company employs 84-members, as of Sept 30, 2024, driving its growth and market penetration.
Experienced and Skilled Workforce: The company has a team of qualified professionals, including engineers, designers, and project managers, ensuring high-quality execution.
Diverse Portfolio across Industries: Proven expertise in catering to multiple sectors, including corporate offices, R&D facilities, and commercial spaces.
Focus on Quality & Sustainability: Commitment to maintaining high-quality standards and adopting sustainable development practices.
Order Uncertainty & Execution Delays: Variability in order inflow and execution timelines can impact revenue and profitability.
Dependence on Repeat Clients: A significant portion of revenue is derived from repeat customers; losing them could impact financial performance.
Client Concentration Risk: Heavy reliance on a few major clients makes the company vulnerable to business risks if any of them exit.
Phone: +91-22-6263 8200
Email: investor@bigshareonline.com
Website: https://ipo.bigshareonline.com/IPO_Status.html